Fortune India has published 2017 list of The Next 500 Companies and ranked various mid-size companies. Granules India Limited features in the list as 60th rank holder. The Company was ranked at 111 in 2016 in the list of The Next 500 Companies. In addition to that Granules India Limited has also received award for being in the elite list of 25 greatest value creators in the Fortune India Next 500 universe.
On 21st of July 2017, Fortune India organized a function to present the awards to Top 25 greatest value creator companies. The award was presented by Mr. Amitabh Kant, CEO Niti Ayog, Government of India and Mr D.N. Mukerjea, Editor, Fortune India.
On this occasion Mr. Krishna Prasad, Chairman and Managing Director, Granules India Limited said “It is indeed a proud moment for all of us at Granules India Limited to be honoured and recognised by Fortune India. The award is the testimony to our continuous effort to create value to all our stakeholders and society at large”.
About Granules India Ltd.
(BSE: 532482, NSE: GRANULES)
Granules India is a growing pharmaceutical manufacturing company with world class facilities and is committed to operational excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and less-regulated markets of the world. Granules support customers with unique value, extensive product range, and proactive solutions. The Company’s global presence extends to over 250 customers in 60 countries through offices in India, U.S., and U.K. Granules offer all three components of the pharmaceutical value chain which gives the customers flexibility and choice.